Boothbay Fund Management, LLC Viking Therapeutics, Inc. Transaction History
Boothbay Fund Management, LLC
- $3.6 Billion
- Q3 2024
A detailed history of Boothbay Fund Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 290,100 shares of VKTX stock, worth $9.45 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
290,100
Previous 61,790
369.49%
Holding current value
$9.45 Million
Previous $3.28 Million
460.79%
% of portfolio
0.51%
Previous 0.1%
Shares
16 transactions
Others Institutions Holding VKTX
# of Institutions
478Shares Held
64.7MCall Options Held
5.76MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$196 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$152 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$68.9 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$61 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.5B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...